Cialis is better

While erectile dysfunction is usually considered a condition that affects older men, it can also be a problem for young males.And some college-aged men are using Viagra in tandem with alcohol or illegal recreational drugs, increasing the likelihood of spreading sexually transmitted diseases, a new study concludes.

Just how widespread the use of Viagra and other similar drugs is among young men is unknown. But judging from the results of the new research — which included 234 sexually active men aged 18 to 25 years old attending three Chicago universities — the drugs appear to be used by a significant number of young men in the United States.

The researchers reported that 13 percent of the young men said they’d experienced erectile dysfunction, but rarely discussed this with a doctor. Erectile dysfunction, or impotence, was defined as ever having difficulty getting or keeping an erection.

The study, the first of its kind, was conducted by researchers from Children’s Memorial Hospital and Northwestern University’s Feinberg School of Medicine, both in Chicago. They were to present their findings Saturday at the Pediatric Academic Societies annual meeting in San Francisco.

“We asked men about erectile dysfunction when using a condom, and 25 percent said they lost an erection while putting on a condom,” said lead researcher Dr. Najah Senno Musacchio, a fellow in general academic pediatrics at Children’s Memorial Hospital. “These men were four times less likely to use condoms consistently, and five times more likely to have six or more sex partners in the last year.”

Musacchio noted this is a public health problem because not using a condom makes transmitting a sexually transmitted disease (STD), more likely.

Among the men who completed the survey, 6 percent said they’d used erectile dysfunction medications; 57 percent said they used the drugs to treat erectile dysfunction, and 29 percent used them to enhance sexual performance.

Viagra won’t make a man who isn’t impotent a “sexual superman,” Musacchio explained. But it may make him able to have sex more often over a shorter period of time, she added.

“Most of these men, (64 percent) mixed these medications with alcohol, methamphetamine, cocaine and ecstasy,” Musacchio said. “Those drugs increase your sex drive, reduce your inhibitions, but may make you less likely to sexually perform. When people mix those drugs with Viagra, they may be able to have sex when they couldn’t normally do so. This is of concern for transmission of STDs and unwanted pregnancies.”

The men surveyed said they almost never got Viagra from a doctor; 54 percent reported getting the drug from friends or through the Internet.

“Health-care providers are out of the loop,” Musacchio said. “They should be asking their patients if they are using erectile dysfunction medications. And if they are, they should be counseled on the hazards of using these medications with other substances.”

One expert agrees that the combined use of Viagra and alcohol and drugs by young men can be a risk for the transmission of STDs.

“It’s hard drawing conclusions from one study,” said Dr. Ira Sharlip, a clinical professor of urology at the University of California, San Francisco, and a spokesman for the American Urological Association. “If it’s true that these medications are being combined with drugs and alcohol and produce risky sexual behavior, then there is an increased risk of undesired pregnancies and sexually transmitted diseases.”

Sharlip doesn’t think that those taking these anti-impotence drugs are at any risk from them unless they’re taking large doses. “I don’t see young people coming in with problems related to these drugs,” he said.

As far as enhancing sexual performance, Sharlip doubts any effect. “I think that it doesn’t do anything to enhance sexuality for young people with normal sexual function,” he said. “My expectation is that those who use it once don’t use it again.”

More information

The National Institute of Diabetes and Digestive and Kidney Diseases can tell you more about erectile dysfunction.

WASHINGTON (AP) — A test to help doctors rapidly distinguish between viral meningitis and less common but more severe spinal cord and brain infections caused by bacteria received federal approval Friday.

The Xpert EV test can give meningitis test results in 2 1/2 hours, or far less than the week it can now take, the Food and Drug Administration said. Sunnyvale, Calif.-based Cepheid developed the test and the company’s shares jumped 78 cents, or 9 percent, to $9.44 on the Nasdaq Stock Market.

Meningitis is an infection of the fluid surrounding the spinal cord and brain. The newly approved test, when used in combination with other laboratory tests, can distinguish between viral and bacterial meningitis. That can minimize delays in treating patients, the FDA said.

Bacterial meningitis can lead to brain damage, hearing loss and even death if not treated. Patients with viral meningitis can recover on their own within two weeks - yet often are treated, ultimately unnecessarily, with antibiotics as a safeguard against bacterial meningitis, the FDA said.

araguay’s Ministry of Health head nurse died last Friday of hemorrhagic dengue an epidemics caused by a mosquito which is rapidly extending in the landlocked South American country and has 15.000 cases officially confirmed.

Maria Catalina Roa became the tenth victim of hemorrhagic dengue or related diseases. She had been involved in fighting the disease since the first cases were reported in Paraguay and for the last two weeks had been in Paraguay’s School of Medicine hospital as a patient.

The dengue epidemic in its two basic forms, the classical which is not fatal and hemorrhagic which is lethal has rapidly extended to the whole country and although official reports mention 15.376 cases, doctors and nurses in the field believe the number is closer to 150.000, which the government considers “exaggerated”.

Paraguayan president Nicanor Duarte declared a 60 days state of “national emergency” and has destined five million US dollars contingency funds to fight the epidemic.

However doctors and nurse last week marched in the capital Asunción demanding the resignation of the Minister of Public Health because of his “negligent” handling of the sanitary crisis.

Paraguay has requested aid from United States and Argentine and this weekend the French government sent a humanitarian and scientific cooperation mission which includes experts from the Pasteur Institute branch in Cayenne (French Guyana) which specializes in tropical diseases.

Paraguayan authorities want foreign scientific aid to help determine the different strains of the epidemics to ensure an appropriate treatment.

Public health authorities revealed that this is the first time death cases because of dengue have been registered in the country and “with the help of epidemiologists and entomologists we expect to find the appropriate treatment for the virulent disease”. Dengue (DF) and dengue hemorrhagic fever (DHF) are caused by one of four closely related, but antigenically distinct, virus serotypes (DEN-1, DEN-2, DEN-3, and DEN-4), of the genus Flavivirus.
Infection with one of these serotypes provides immunity to only that serotype for life, so persons living in a dengue-endemic area can have more than one dengue infection during their lifetime.

DF and DHF are primarily diseases of tropical and sub tropical areas, and the four different dengue serotypes are maintained in a cycle that involves humans and the Aedes mosquito. However, Aedes aegypti, a domestic, day-biting mosquito that prefers to feed on humans, is the most common Aedes species.

Infections produce a spectrum of clinical illness ranging from a nonspecific viral syndrome to severe and fatal hemorrhagic disease.

Important risk factors for DHF include the strain of the infecting virus, as well as the age, and especially the prior dengue infection history of the patient.

Paraguay with a population of approximately 6.5 million and a tropical climate has launched a massive national campaign to eliminate stagnant water and deposits of untreated organic matter.

Meantime in the northern provinces of Argentina thousands of people had to be evacuated because of intense rains and flooding and local authorities fear the dengue epidemic in Paraguay could make its appearance.

Authorities are particularly concerned with stagnant waters where the mosquito larvae prosper and could easily begin spreading the disease.

In the northern provinces of Argentine so far 30 cases of mild dengue have been reported.

FDA Public Health Advisory for Crestor (rosuvastatin)

Astra-Zeneca Pharmaceuticals today released a revised package insert for Crestor (rosuvastatin) for use in the 22 member states of the European Union (EU). The changes to the European labeling are in response to postmarketing spontaneous adverse event reports in patients receiving Crestor and highlight certain patient populations who may be at an increased risk for serious muscle toxicity (myopathy) associated with Crestor use, especially at the highest approved dose of 40 mg. These risk factors and many of the recommendations for how to minimize the risk of myopathy are already captured in the FDA approved labeling for Crestor in the U.S. FDA is alerting physicians to the need to carefully read the Crestor product label and follow the recommendations for starting doses, dose adjustments, and maximum daily doses to minimize the risk of myopathy in individual patients.

Crestor, a member of a class of cholesterol-lowering drugs commonly referred to as “statins”, was approved in the U.S. in August 2003, based on review of an extensive clinical database involving approximately 12,000 patients. At that time, the FDA identified in the WARNINGS section of the product label those patients whose increased baseline risk for myopathy warranted more careful monitoring when prescribed Crestor. The U.S. approved labeling included a specific section titled, “Myopathy/Rhabdomyolysis”, which states that patients who are of advanced age (³ 65 years), have hypothyroidism, and/or renal insufficiency should be considered to have a greater risk for developing myopathy while receiving a statin. Physicians are warned to prescribe Crestor with caution in these patients, particularly at higher doses, as the risk of myopathy increases with higher drug levels.

In addition, the U.S. approved labeling for Crestor states that increased rosuvastatin drug levels were observed in certain sub-populations of patients (e.g., subgroups of Asians, patients concomitantly using cyclosporine and gemfibrozil), conferring increased risk of myopathy. Because of these findings, the FDA required Astra-Zeneca to make available in the U.S. a 5-mg dose that could be used in patients requiring less aggressive cholesterol-lowering or who were taking concurrent cyclosporine. The maximum recommended dose in the FDA-approved label is limited to 10 mg daily in patients with severe renal impairment or who are also taking gemfibrozil.

FDA has received reports of rhabdomyolysis in association with Crestor, as it has with other drugs in the statin class. In ongoing fashion, we are evaluating these reports of adverse muscle effects with regard to clinical severity and apparent relationship to the drug. FDA is comparing the frequency of reporting of muscle injury with Crestor to that with other statins, given differences in prescribing rates for the different drugs. Pending the evaluation of the recent Crestor safety experience, FDA is not proposing to change the US labeling for Crestor, but does want to re-emphasize to physicians to the importance of carefully following the recommendations in the current product label. Analysis of accumulating safety data in the U.S. and worldwide will be considered in any future labeling changes for Crestor, and to make recommendations on risk management plans for Crestor.

Healthcare professionals prescribing Crestor are reminded of the following key safety messages from the Crestor label: start doses and maintenance doses of drug should be based on individual cholesterol goals and apparent risks for side-effects; all patients should be informed that statins can cause muscle injury, which in rare, severe cases, can cause kidney damage and other organ failure that are potentially life-threatening; and patients should be told to promptly report to their physician signs or symptoms of muscle pain and weakness, malaise, fever, dark urine, nausea, or vomiting.

Sex is important for life because it keeps two sex partners together both physically and emotionally. Normal sex life is necessary for a successful married life. Not having a normal sex life can be very annoying and make you and your partner feels down and less important.
Erectile dysfunction is a problem which creates so many difficulties in a normal sex life. Erectile dysfunction or ED which is also known impotence is basically a situation in which penis is not able to erect or sustain erection.
Every man in this world suffers from this erection problem in his life. The reason behind it may be physical or psychological. Many people fail to get proper erection in his first sexual intercourse. These failures in erection are not ED problem but an obvious situation which occurs due anxiety and extreme excitement to have intercourse for the first time.
In the past time Erectile dysfunction was occurs due to psychological problem but now a days so many people are having this sexual disorder because of their physical problems. Some other reasons of erectile dysfunction are lack of exercise, laziness, over consumption of alcohol, drugs and diseases like diabetes. Thus, one must envisage all these factors to prevent himself from the clutches of ED.
But there is good news for the person who is suffering from this embarrassing and guilt disease is that Erectile dysfunction is treatable easily. There are so many anti ED drugs are available in the markets which are affective in erectile dysfunction problem.
The anti impotency pill Kamagra or generic Viagra has been tested for its efficiency on millions of ED patients and results were almost 100% positive.
Kamagra is an alternate of viagra. It is available in the form of tablet and oral jelly. In compare to tablet the jelly starts work more quickly but it is more expensive. But it is cheaper then viagra. People are finding it easy to buy Kamagra on a click of mouse and at a comfort of bedroom. Due to its better result and easy availability the sales of cheap Generic Viagra are increasing at a rapid rate.